Skip to main content
. 2016 Jan 1;37(6):2137–2148. doi: 10.1177/0271678X16661339

Table 1.

Regional [11C]Ro15-4513 parameters derived from 2TCM and competition binding analysis.

Model selection 2TCM
ROI
AIC
VT baseline
K1 baseline (ml·min−1·cm−3)
K1 drug (ml·min−1·cm−3)
Vα5 (ml·cm−3)
Vαxa (ml·cm−3)

VSVT

Vα5Vα5+Vαx
1TCM 2TCM Diff Mean [±95% CI] Mean [±95% CI] Mean [±95% CI] Mean [±95% CI] Mean [±95% CI]
Insular ctx −141.5 −169.2 27.6 8.97 [7.16, 10.78] 0.42 [0.39, 0.45] 0.42 [0.39, 0.45] 4.86 [4.29, 5.44] 2.05 [1.61, 2.49] 0.77 0.70
Anterior cingulate −147.0 −171.7 24.7 7.16 [6.75, 7.57] 0.4 [0.37, 0.43] 0.4 [0.38, 0.42] 4.38 [3.81, 4.95] 1.92 [1.49, 2.35] 0.51 0.70
Cingulate ctx −147.2 −167.7 20.4 6.46 [6.07, 6.85] 0.39 [0.36, 0.42] 0.41 [0.38, 0.44] 3.75 [3.19, 4.31] 1.88 [1.47, [2.30] 0.87 0.67
Occipital lobe −171.3 −181.1 9.7 4.37 [4.17, 4.57] 0.4 [0.37, 0.43] 0.41 [0.38, 0.44] 1.67 [1.17, 2.18] 1.87 [1.48, 2.25] 0.81 0.47
Temporal lobe −154.2 −182.7 28.5 5.70 [5.38, 6.02] 0.32 [0.30, 0.34] 0.33 [0.31, 0.35] 3.12 [2.56, 3.67] 1.73 [1.33, 2.14] 0.85 0.64
Parietal lobe −168.7 −180.3 11.5 4.51 [4.27, 4.75] 0.4 [0.37, 0.43] 0.4 [0.37, 0.43] 2.03 [1.52, 2.54] 1.65 [1.26, 2.03] 0.82 0.55
Frontal lobe −163.1 −183.4 20.3 4.85 [4.58, 5,12] 0.37 [0.34, 0.40] 0.38 [0.35, 0.41] 2.55 [2.01, 3.10] 1.49 [1.07, 1.91] 0.83 0.63
Parahippocampal gyrus −149.6 −170.7 21.0 7.08 [5.80, 8.36] 0.26 [0.24, 0.28] 0.27 [0.26, 0.28] 3.92 [3.37, 4.48] 1.57 [1.15, 1.98] 0.78 0.71
Cerebellum −181.5 −179.0 −2.4 2.29 [2.15, 2.43] 0.39 [0.36, 0.42] 0.42 [0.39, 0.45] 0.15 [−0.37, 0.67] 1.36 [0.98, 1.74] 0.66 0.10
Accumbens −127.5 −165.1 37.6 11.05 [8.24, 13.86] 0.42 [0.39, 0.45] 0.41 [0.39, 0.43] 6.58 [5.96, 7.21] 1.63 [1.15, 2.11] 0.74 0.80
Hippocampus −137.7 −177.7 40.0 8.13 [6.46, 9.80] 0.31 [0.30, 0.32] 0.32 [0.30, 0.34] 4.85 [4.29, 5.40] 1.49 [1.05, 1.93] 0.78 0.76
Amygdala −138.7 −170.0 31.3 7.23 [6.45, 8.01] 0.3 [0.28, 0.32] 0.29 [0.27, 0.31] 5.12 [4.55, 5.69] 1.18 [0.72, 1.65] 0.87 0.81
Caudate −155.2 −175.7 20.5 3.47 [3.25, 3.69] 0.38 [0.35, 0.41] 0.37 [0.34, 0.40] 2.06 [1.51, 2.62] 0.63 [0.22, 1.04] 0.31 0.77
Putamen −142.6 −174.1 31.5 4.75 [4.31, 5.19] 0.45 [0.42, 0.48] 0.45 [0.43, 0.47] 2.97 [2.44, 3.51] 0.85 [0.44, 1.25] 0.80 0.78
Thalamus −172.0 −183.0 11.1 3.01 [2.76, 3.26] 0.37 [0.35, 0.39] 0.37 [0.35, 0.39] 1.52 [1.01, 2.03] 0.65 [0.27, 1.03] 0.72 0.70
Midbrain −178.6 −180.3 1.6 1.63 [1.47, 1.79] 0.3 [0.28, 0.32] 0.32 [0.31, 0.33] 0.47 [−0.05, 0.99] 0.36 [−0.02, 0.74] 0.51 0.57
Medulla −171.2 −168.8 −2.3 1.00 [0.92, 1.08] 0.19 [0.16, 0.22] 0.2 [0.18, 0.22] 0.11 [−0.42, 0.65] 0.07 [−0.33, 0.47] 0.18 0.61
Pons −190.5 −188.6 −1.8 0.91 [0.83, 0.99] 0.24 [0.23, 0.25] 0.24 [0.22, 0.26] 0.11 [−0.40, 0.63] 0.01 [−0.38, 0.40] 0.13 0.92

AIC: Akaike Information Criteria for model selection (smaller number indicates preferred model); VT: total distribution volume; K1: Delivery; Vα5: α5 specific binding; Vαx: non-selective specific binding; VS=Vα5+Vαx: total specific binding.

a

Under the assumption that VND is accurate and invariant across regions, mean and CI were calculated equal to VT-Vα5-0.78.